Oncternal Therapeutics | EFFECT: Others
Oncternal Therapeutics | 424B5: Prospectus
Oncternal Therapeutics | 424B5: Prospectus
Oncternal Therapeutics | EFFECT: Others
Oncternal Therapeutics | 424B3: Prospectus
Oncternal Therapeutics | 424B5: Prospectus
Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Oncternal Therapeutics | 424B5: Prospectus
Oncternal Therapeutics | 424B5: Prospectus
Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Oncternal Therapeutics | 424B5: Prospectus
Oncternal Therapeutics | 424B5: Prospectus
Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Oncternal Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Oncternal Therapeutics | 424B5: Prospectus
Oncternal Therapeutics | 424B5: Prospectus
Oncternal Therapeutics | 424B5: Prospectus
Oncternal Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
No Data